Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.74+0.01 (+0.07%)
Close on Nov 13, 2026Market cap $12.30BP/E 26.9Yield 0.58%
Dr Reddys Laboratories enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Dr Reddys Laboratories's enterprise value was $13.04B on Nov 11, 2026, against $12.10B a year earlier. Over the last 5 years it ranged from $8.77B to $14.02B, with a median of $11.57B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.04B | +7.9% |
| 2025 | Dec 31, 2025 | $12.09B | -8.9% |
| 2024 | Dec 31, 2024 | $13.27B | +14.0% |
| 2023 | Dec 29, 2023 | $11.64B | +32.2% |
| 2022 | Dec 30, 2022 | $8.81B | -20.3% |
| 2021 | Dec 31, 2021 | $11.05B | -8.6% |
| 2020 | Dec 31, 2020 | $12.10B | +67.1% |
| 2019 | Dec 31, 2019 | $7.24B | +4.3% |
| 2018 | Dec 31, 2018 | $6.94B | -2.5% |
| 2017 | Dec 29, 2017 | $7.12B | -7.8% |
| 2016 | Dec 30, 2016 | $7.71B | – |
See a number that looks wrong?